XL999 Completed Phase 1 Trials for Advanced Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00955084Maintenance Study on the Long Term Safety of XL999